These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
43. [Ergotism and HIV]. Finn BC; Vadalá S; Meraldi A; Bruetman JE; Martínez JV; Young P Medicina (B Aires); 2013; 73(4):346-8. PubMed ID: 23924536 [TBL] [Abstract][Full Text] [Related]
44. [Ergotism in migraine. Peripheral vascular complications in 14 patients with migraine]. Aabech J; Jensen FB; Engell HC Ugeskr Laeger; 1989 Aug; 151(33):2067-70. PubMed ID: 2773132 [TBL] [Abstract][Full Text] [Related]
45. Gastrointestinal vascular ischemia caused by ergotamine. Rogers DA; Mansberger JA South Med J; 1989 Aug; 82(8):1058-9. PubMed ID: 2503892 [TBL] [Abstract][Full Text] [Related]
46. Ergotism with ischemia in all four extremities: a case report. Jeong SY; Lim ES; Shin BS; Seo MW; Kim YH; Kwak HS; Chung GH; Jeong SK J Clin Neurol; 2006 Dec; 2(4):279-82. PubMed ID: 20396534 [TBL] [Abstract][Full Text] [Related]
49. Comparison of intravenous nitroglycerin and sodium nitroprusside in acute myocardial infarction. Flaherty JT Am J Med; 1983 Jun; 74(6B):53-60. PubMed ID: 6407315 [TBL] [Abstract][Full Text] [Related]
50. Successful limb salvage with prostaglandin infusion: a review of ergotamine toxicity. Edwards RJ; Fulde GW; McGrath MA Med J Aust; 1991 Dec 2-16; 155(11-12):825-7. PubMed ID: 1745181 [TBL] [Abstract][Full Text] [Related]
51. Nitroglycerin for ergotism. Experimental studies in vitro and in migraine patients and treatment of an overt case. Tfelt-Hansen P; Ostergaard JR; Gøthgen I; Jacobsen E; Rasmussen JP; Husum B Eur J Clin Pharmacol; 1982; 22(2):105-9. PubMed ID: 6807695 [TBL] [Abstract][Full Text] [Related]
52. Use of a microprocessor in the control of malignant hypertension with sodium nitroprusside. Jackson RV; Love JB; Parkin WG; Wahlqvist ML; Williams NS Aust N Z J Med; 1977 Aug; 7(4):414-7. PubMed ID: 270994 [TBL] [Abstract][Full Text] [Related]
53. Ergotamine: its use in the treatment of migraine and its complications. Saxena VK; De Deyn PP Acta Neurol (Napoli); 1992 Apr; 14(2):140-6. PubMed ID: 1329442 [TBL] [Abstract][Full Text] [Related]
54. Ergotism and vascular insufficiency: a case report and review of literature. Tay JC; Chee YC Ann Acad Med Singap; 1998 Mar; 27(2):285-8. PubMed ID: 9663328 [TBL] [Abstract][Full Text] [Related]
55. Mitral regurgitation caused by chronic ergotamine use. Flaherty KR; Bates JR Am Heart J; 1996 Mar; 131(3):603-6. PubMed ID: 8604645 [No Abstract] [Full Text] [Related]
56. Severe facial ischaemia caused by ergotism. Lazarides MK; Karageorgiou C; Tsiara S; Grillia M; Dayantas JN J Cardiovasc Surg (Torino); 1992; 33(3):383-5. PubMed ID: 1601926 [TBL] [Abstract][Full Text] [Related]
57. Acute Ischemia of Lower Extremities Caused by Ergotamine Toxicity due to Pharmacologic Interaction With Cobicistat in an HIV-Positive Patient. Hostench-Junoy N; Ramírez-Montoya M; Arefai-Refai B; Estal-Jiménez J; Santana-Rodríguez ZJ; Costa-Pérez L Ann Vasc Surg; 2022 Mar; 80():392.e1-392.e6. PubMed ID: 34775015 [TBL] [Abstract][Full Text] [Related]
58. Ergot intoxication: historical review and description of unusual clinical manifestations. Merhoff GC; Porter JM Ann Surg; 1974 Nov; 180(5):773-9. PubMed ID: 4371616 [TBL] [Abstract][Full Text] [Related]